GO:0032498 detection of muramyl dipeptide: NOD2 Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032498 detection of muramyl dipeptide describes the biological process by which a cell senses muramyl dipeptide (MDP), a peptidoglycan-derived fragment, and converts it into a molecular signal.
• The canonical sensor for MDP is NOD2 (nucleotide-binding oligomerization domain-containing protein 2), which directly binds MDP to initiate innate immune signaling.
• Phosphorylation of MDP by N-acetylglucosamine kinase (NAGK) is required for efficient NOD2 activation, adding a metabolic checkpoint to MDP detection.
• Defects in MDP sensing are linked to Crohn's disease, where impaired NOD2-mediated detection of MDP contributes to inflammatory bowel disease pathogenesis.
• MDP detection can be enhanced by self-derived peptides and is being exploited for immunoconjugate-based anti-leukemia therapies [6,8].
• Research tools for studying GO:0032498 include NOD2 knockout and knock-in cell models, MDP conjugates for binding assays, and CRISPR screening to identify modifiers of MDP sensing.
Description
GO:0032498 detection of muramyl dipeptide is a biological process defined as the series of events in which a muramyl dipeptide stimulus is received by a cell and converted into a molecular signal. Muramyl dipeptide (MDP) is a minimal bioactive fragment of peptidoglycan, a major component of bacterial cell walls. This process is central to innate immune recognition of bacteria and is primarily mediated by the cytosolic sensor NOD2. Understanding MDP detection is critical for immunology, microbiology, and inflammatory disease research. The detection of MDP by NOD2 triggers NF-kB activation and pro-inflammatory cytokine production, which are essential for host defense but can also contribute to chronic inflammation when dysregulated. Defects in this pathway have been directly implicated in Crohn's disease, where patients exhibit impaired MDP-sensing responses. Moreover, MDP detection is being explored for therapeutic applications, including vaccine adjuvants and anti-leukemia immunoconjugates. Recent studies have revealed that MDP phosphorylation by NAGK is a prerequisite for NOD2 activation, highlighting a metabolic layer of regulation. This article provides a research-grade overview of the ontology, mechanisms, key genes, disease links, and experimental models for studying GO:0032498.
detection of muramyl dipeptide At A Glance
| GO ID | GO:0032498 |
|---|---|
| GO term | detection of muramyl dipeptide |
| Ontology | biological_process |
| Synonym | none |
| Major function | Recognition of muramyl dipeptide and initiation of innate immune signaling |
| Key sensor | NOD2 |
| Stimulus | Muramyl dipeptide (MDP), a peptidoglycan fragment |
| Downstream effect | NF-kB activation and pro-inflammatory cytokine production |
| Disease relevance | Crohn's disease, inflammatory bowel disease, leukemia immunotherapy |
What Is GO:0032498?
GO:0032498 detection of muramyl dipeptide is the biological process in which a cell receives a muramyl dipeptide (MDP) stimulus and converts it into a molecular signal. MDP is a peptidoglycan-derived molecule, and its detection typically involves direct binding by pattern-recognition receptors such as NOD2, leading to downstream signaling events.
Why Is detection of muramyl dipeptide Important in Cell Biology?
GO:0032498 detection of muramyl dipeptide is a cornerstone of innate immunity because it allows host cells to sense bacterial peptidoglycan fragments and mount a rapid inflammatory response. This process is essential for clearing bacterial infections, but its dysregulation is directly linked to chronic inflammatory diseases such as Crohn's disease. Furthermore, MDP detection is being harnessed for immunotherapeutic strategies, including anti-leukemia immunoconjugates. Understanding the molecular details of MDP detection, including the role of NAGK-mediated phosphorylation, opens new avenues for therapeutic intervention.
• MDP detection by NOD2 is a primary mechanism for innate immune recognition of bacterial peptidoglycan.
• Defective MDP sensing is observed in a subset of Crohn's disease patients, linking this process to inflammatory bowel disease.
• MDP phosphorylation by NAGK is required for NOD2 activation, revealing a metabolic checkpoint in MDP detection.
• Self-derived peptides can enhance MDP-dependent NOD2 activity, suggesting endogenous modulators of this pathway.
• MDP-based immunoconjugates enhance anti-leukemia immunity, demonstrating therapeutic potential of MDP detection pathways.
• Erbin regulates lysosome biogenesis and autophagy, which may intersect with MDP detection during sepsis.
• MDP detection is a target for vaccine adjuvant development due to its immunostimulatory properties.
• Analytical methods such as HPLC-MS/MS enable pharmacokinetic studies of MDP-based drugs.
• Solid-phase synthesis of MDP conjugates facilitates detection of NOD2 and study of MDP sensing.
• Understanding MDP detection can inform strategies to modulate inflammation in sepsis and autoimmune conditions.
What Happens During detection of muramyl dipeptide?
Recognition of Muramyl Dipeptide by NOD2
In simple terms: The cell uses a sensor called NOD2 to grab onto MDP, a piece of bacterial cell wall.
The detection of muramyl dipeptide begins with its direct binding to NOD2, a cytosolic pattern-recognition receptor. Girardin et al. demonstrated that NOD2 is a general sensor of peptidoglycan through specific detection of MDP. This binding event is the initial step that converts the presence of MDP into a molecular signal. NOD2 contains leucine-rich repeats (LRRs) that mediate MDP recognition, and upon binding, NOD2 undergoes conformational changes that lead to oligomerization and recruitment of downstream adaptor proteins.
Phosphorylation of MDP by NAGK
In simple terms: Before NOD2 can fully respond, MDP must be chemically modified by an enzyme called NAGK.
Stafford et al. discovered that phosphorylation of muramyl peptides by N-acetylglucosamine kinase (NAGK) is required for NOD2 activation. This phosphorylation step acts as a metabolic checkpoint, ensuring that only appropriately modified MDP can trigger efficient NOD2 signaling. The study showed that NAGK-deficient cells exhibit impaired NOD2 activation in response to MDP, highlighting the importance of this modification in the detection process.
Downstream Signaling and NF-kB Activation
In simple terms: Once NOD2 detects MDP, it sets off a chain reaction that turns on inflammatory genes.
After MDP binding, NOD2 recruits the adaptor protein RIP2 (RICK), leading to activation of the NF-kB pathway and MAP kinase cascades. This results in the production of pro-inflammatory cytokines and antimicrobial peptides. The signaling cascade is tightly regulated to prevent excessive inflammation. Mann et al. showed that a self-derived peptide can enhance MDP-dependent NOD2 activity, indicating additional layers of regulation.
Modulation by Erbin and Lysosomal Pathways
In simple terms: Other proteins like Erbin can influence how strongly the MDP detection pathway responds.
Fang et al. reported that Erbin accelerates TFEB-mediated lysosome biogenesis and autophagy, alleviating sepsis-induced inflammatory responses. Although this study focuses on sepsis, it suggests that lysosomal and autophagic pathways can modulate innate immune signaling, potentially intersecting with MDP detection. This highlights the broader cellular context in which MDP detection operates.
Key Genes Involved in GO:0032498 detection of muramyl dipeptide
The following genes and proteins are central to the detection of muramyl dipeptide (GO:0032498) and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOD2 | Cytosolic sensor that directly binds muramyl dipeptide and initiates signaling | Mutations linked to Crohn's disease; target for knockout and knock-in studies |
| NAGK | Phosphorylates muramyl peptides, required for NOD2 activation | Metabolic checkpoint; knockout models show impaired MDP sensing |
| RIP2 (RICK) | Adaptor protein recruited by NOD2 to activate NF-kB | Essential for downstream signaling; knockout reduces inflammatory response |
| TFEB | Transcription factor regulating lysosome biogenesis and autophagy | Modulated by Erbin; may influence MDP detection indirectly |
| Erbin | Scaffold protein that promotes TFEB-mediated lysosome biogenesis | Alleviates sepsis-induced inflammation; potential regulator of MDP pathway |
| ATG5 | Autophagy-related protein involved in autophagosome formation | May intersect with MDP detection through autophagy |
| ATG7 | Autophagy-related protein essential for autophagosome formation | Potential modifier of MDP-induced inflammation |
| NF-kB1 | Transcription factor subunit downstream of NOD2 | Readout of MDP detection; knockout blocks cytokine production |
| MAPK1 | Mitogen-activated protein kinase involved in NOD2 signaling | Contributes to inflammatory gene expression |
| IL6 | Pro-inflammatory cytokine produced upon MDP detection | Biomarker of NOD2 activation |
| TNF | Pro-inflammatory cytokine induced by MDP | Readout of MDP detection in cell models |
| CD10 (MME) | Target for MDP immunoconjugates in leukemia | Enhances anti-leukemia immunity |
| LYZ | Lysozyme, produces muramyl dipeptide from peptidoglycan | Upstream of MDP detection; knockout affects MDP availability |
| PGLYRP1 | Peptidoglycan recognition protein | May modulate MDP detection |
| CARD9 | Adaptor in antifungal and antibacterial signaling | Potential crosstalk with NOD2 pathway |
| TRAF6 | E3 ubiquitin ligase in NF-kB activation | Downstream of NOD2; knockout impairs signaling |
| IKBKB | IKK-beta kinase essential for NF-kB activation | Required for MDP-induced cytokine production |
How Is detection of muramyl dipeptide Regulated?
The detection of muramyl dipeptide is regulated at multiple levels. Phosphorylation of MDP by NAGK is a prerequisite for NOD2 activation, acting as a metabolic gatekeeper. Additionally, self-derived peptides can enhance MDP-dependent NOD2 activity, suggesting endogenous positive regulators. Erbin promotes TFEB-mediated lysosome biogenesis and autophagy, which can modulate inflammatory responses and potentially influence MDP detection. Furthermore, the pathway is subject to negative feedback through ubiquitination and degradation of signaling components, though specific regulators in MDP detection require further study.
detection of muramyl dipeptide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOD2 | Crohn's disease; impaired MDP sensing | NOD2 knockout and knock-in (e.g., 1007fs, R702W) in intestinal epithelial cells [3,7] |
| NAGK | Inflammatory bowel disease; metabolic checkpoint | NAGK knockout macrophages and epithelial cells |
| CD10 (MME) | Leukemia; immunoconjugate target | CD10-positive leukemia cell lines treated with MDP-anti-CD10 immunoconjugate |
| Erbin | Sepsis; inflammation and organ injury | Erbin knockout mice and macrophages |
| TFEB | Lysosomal dysfunction; inflammation | TFEB overexpression and knockout in macrophages |
Crohn's Disease and Inflammatory Bowel Disease
Defects in the detection of muramyl dipeptide are strongly associated with Crohn's disease. van Heel et al. demonstrated that patients with Crohn's disease exhibit impaired MDP-sensing pathway responses, linking GO:0032498 to inflammatory bowel disease pathogenesis. NOD2 mutations, particularly in the LRR domain, are the strongest genetic risk factors for Crohn's disease, and these mutations impair MDP detection. This highlights the clinical importance of understanding MDP sensing for diagnosing and treating IBD.
Leukemia and Immunotherapy
MDP detection pathways are being exploited for cancer immunotherapy. Wang et al. showed that a muramyl dipeptide and anti-CD10 monoclonal antibody immunoconjugate enhances anti-leukemia immunity of T lymphocytes. This approach leverages the immunostimulatory properties of MDP to target leukemia cells, demonstrating a therapeutic application of MDP detection mechanisms.
Sepsis and Inflammatory Responses
Erbin, a protein that modulates lysosome biogenesis and autophagy, alleviates sepsis-induced inflammatory responses and organ injuries. Although not directly studying MDP detection, this research suggests that regulators of innate immunity can impact MDP-induced inflammation. Sepsis is characterized by excessive inflammatory responses to bacterial components, including MDP, making this pathway a potential therapeutic target.
From detection of muramyl dipeptide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NOD2 mediate MDP detection? | NOD2 knockout cell lines (e.g., HEK293T, THP-1) |
| What is the role of NAGK in MDP sensing? | NAGK knockout macrophages and epithelial cells |
| How do Crohn's disease-associated NOD2 variants affect MDP detection? | NOD2 point-mutation knock-in (e.g., R702W, G908R, 1007fs) |
| Can MDP detection be enhanced for immunotherapy? | MDP-anti-CD10 immunoconjugate in leukemia models |
| What proteins interact with NOD2 upon MDP stimulation? | Tagged NOD2 knock-in for proteomics |
| Does Erbin regulate MDP-induced inflammation? | Erbin overexpression and knockout in sepsis models |
How to Study the detection of muramyl dipeptide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NF-kB luciferase reporter assay | NF-kB activation downstream of MDP detection | Screening for NOD2 agonists/antagonists |
| ELISA for IL-6/TNF | Cytokine production upon MDP stimulation | Functional readout in patient cells |
| MDP conjugate pull-down | Direct binding of MDP to NOD2 | Studying MDP-NOD2 interaction |
| HPLC-MS/MS | Concentration of MDP in plasma | Pharmacokinetic studies |
| CRISPR knockout screening | Identification of genes required for MDP detection | Genome-wide screens |
| RNA-seq | Transcriptional changes upon MDP stimulation | Pathway analysis |
| Proteomics | Protein interactions and modifications | Identifying NOD2 interactome |
| Immunofluorescence | Cellular localization of NOD2 and signaling components | Visualizing MDP detection |
NF-kB Reporter Assays
NF-kB luciferase reporter assays are widely used to measure MDP detection. Cells expressing NOD2 are stimulated with MDP, and luciferase activity reflects downstream NF-kB activation. This method is quantitative and suitable for high-throughput screening of modifiers of MDP sensing.
Cytokine Production Assays
ELISA and multiplex assays measure pro-inflammatory cytokines such as IL-6 and TNF produced upon MDP detection. These assays provide a functional readout of NOD2 activation and are used to study patient-derived cells with MDP-sensing defects.
MDP Conjugate Binding Assays
Solid-phase synthesis of MDP conjugates enables detection of NOD2 binding. Kekessie et al. developed a solid-phase approach for synthesizing MDP conjugates for detection of NOD2. These conjugates can be used in pull-down assays, flow cytometry, and imaging to study MDP-NOD2 interactions.
Pharmacokinetic Analysis by HPLC-MS/MS
Moskaleva et al. developed an HPLC-MS/MS method for determining glucosaminyl-muramyl dipeptide in human plasma, enabling pharmacokinetic studies. This method is essential for evaluating MDP-based therapeutics and understanding MDP bioavailability.
How CRISPR Can Be Used to Study GO:0032498 detection of muramyl dipeptide
Knockout
CRISPR knockout of NOD2 or NAGK is used to abolish MDP detection and study downstream effects. For example, NAGK knockout cells show impaired NOD2 activation upon MDP stimulation. Knockout models are essential for validating the requirement of specific genes in GO:0032498.
Point Mutation
Point mutations in NOD2, such as R702W, G908R, and 1007fs, are associated with Crohn's disease and impaired MDP sensing. CRISPR point-mutation knock-in models recapitulate these patient-specific variants to study their impact on MDP detection and inflammatory responses.
Knock-in
Knock-in of tagged NOD2 (e.g., FLAG or GFP) allows for detection and purification of the receptor for interaction studies. Knock-in of MDP-responsive reporters can also be used to monitor pathway activation in real time.
Overexpression
Overexpression of NOD2 or NAGK enhances MDP detection and downstream signaling, useful for gain-of-function studies [1,7]. Overexpression models can help identify rate-limiting components and potential therapeutic targets.
How EDITGENE Supports detection of muramyl dipeptide Research
Researchers studying detection of muramyl dipeptide-related genes often need to determine whether a candidate gene is causally involved in MDP sensing, how specific mutations affect NOD2 function, or whether a gene product can modulate the pathway. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for detection of muramyl dipeptide research.
Frequently Asked Questions About detection of muramyl dipeptide
What is GO:0032498 detection of muramyl dipeptide?
GO:0032498 is a Gene Ontology biological process term describing the series of events in which a cell receives a muramyl dipeptide stimulus and converts it into a molecular signal.
What genes are involved in detection of muramyl dipeptide?
Key genes include NOD2, NAGK, RIP2, and downstream signaling components such as NF-kB1 and MAPK1 [1,7].
How does NOD2 detect muramyl dipeptide?
NOD2 directly binds muramyl dipeptide through its leucine-rich repeats, triggering oligomerization and recruitment of RIP2 to activate NF-kB.
Why is NAGK important for MDP detection?
NAGK phosphorylates muramyl peptides, a modification required for efficient NOD2 activation.
What diseases are linked to defective MDP detection?
Crohn's disease and inflammatory bowel disease are strongly linked to impaired MDP sensing due to NOD2 mutations.
Can MDP detection be targeted for cancer therapy?
Yes, MDP-anti-CD10 immunoconjugates enhance anti-leukemia immunity by exploiting MDP detection pathways.
What experimental models are used to study MDP detection?
Common models include NOD2 knockout and knock-in cell lines, NAGK knockout macrophages, and NF-kB reporter assays [1,3,7].
How is MDP detection measured in the lab?
NF-kB luciferase reporter assays, cytokine ELISAs, and MDP conjugate binding assays are standard methods [4,7].
What is the role of Erbin in MDP detection?
Erbin promotes TFEB-mediated lysosome biogenesis and autophagy, which may modulate inflammatory responses associated with MDP detection.
Are there pharmacological tools to study MDP detection?
MDP itself and its conjugates are used as agonists; HPLC-MS/MS methods allow pharmacokinetic analysis of MDP-based drugs [2,4].
Conclusion
GO:0032498 detection of muramyl dipeptide is a fundamental innate immune process that enables cells to sense bacterial peptidoglycan fragments and mount an inflammatory response. The pathway is primarily mediated by NOD2 and regulated by NAGK-mediated phosphorylation [1,7]. Defects in MDP detection are directly linked to Crohn's disease, and the pathway is being explored for cancer immunotherapy [3,8]. Continued research using CRISPR models and advanced screening methods will further elucidate the molecular details and therapeutic potential of this process.
References
- 1. Stafford CA et al.. 2022. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.. Nature 609(7927):590-596 PMID: 36002575
- 2. Moskaleva NE et al.. 2020. Determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using HPLC-MS/MS and its application to a pharmacokinetic study.. Biomed Chromatogr 34(12):e4948 PMID: 32652605
- 3. van Heel DA et al.. 2006. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease.. Inflamm Bowel Dis 12(7):598-605 PMID: 16804397
- 4. Kekessie I et al.. 2021. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2.. Bioorg Chem 116:105360 PMID: 34562676
- 5. Fang Q et al.. 2023. Erbin accelerates TFEB-mediated lysosome biogenesis and autophagy and alleviates sepsis-induced inflammatory responses and organ injuries.. J Transl Med 21(1):916 PMID: 38105228
- 6. Mann JK et al.. 2017. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.. J Cell Biochem 118(5):1227-1238 PMID: 27791288
- 7. Girardin SE et al.. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.. J Biol Chem 278(11):8869-72 PMID: 12527755
- 8. Wang LZ et al.. 2016. Muramyl dipeptide and anti-CD10 monoclonal antibody immunoconjugate enhances anti-leukemia immunity of T lymphocytes.. APMIS 124(9):800-4 PMID: 27307219
